The International Registry for Leigh Syndrome
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT03137355
- Status
- Recruiting
Conditions
- Leigh Disease
- Leigh Syndrome
- Leigh's Necrotizing Encephalopathy
- Subacute Necrotizing Encephalomyelopathy
- Subacute Necrotizing Encephalomyopathy
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Days - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.
Key Dates
- Start date
- Jun 17, 2015
- Status verified
- Nov 2023
- Primary completion
- Jun 17, 2030
- Completion
- Jun 17, 2030
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Leigh syndromeAll people diagnosed with Leigh syndrome.
Primary Outcome Measure
Phenotypical characteristics of Leigh syndrome [ Time Frame: 10 years ]
Central Contacts
- Mary Kay Koenig, MD713-500-7164
- William Guerra713-500-7164
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of MetabolismRecruiting · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruiting · Sanford Health · Sioux Falls, South Dakota
- Sirolimus for Leigh SyndromePHASE2 · Enrolling By Invitation · Matthew Demczko · Philadelphia, Pennsylvania